There is a growing need for behavioral readouts to monitor disease progression and to assess the success of a potential therapy. In vision research, observing the optomotor reflex (OMR) is an important and widely established method for assessing visual acuity and contrast sensitivity in rodents. These tests can be performed with freely moving animals without any need for anaesthesia or restraints. In addition, since OMR is a reflex-based behavior, observing it does not require any training of the animal.
In this webinar, sponsored by Striatech and supported in part by Stoelting, researchers will present objective and bias-free results obtained using a newly developed automated optomotor system. For more information, please visit: https://insidescientific.com/webinar/measuring-visual-acuity-contrast-sensitivity-optomotor-reflex-striatech
Measuring visual acuity and contrast sensitivity by optomotor reflex in rodents
1. Measuring Visual Acuity and
Contrast
Sensitivity by Optomotor Reflex
in Rodents
Experts discuss case studies and experimental data from
various applications using a newly developed automated
system to measure vision based on the optomotor reflex.
2. Measuring Visual Acuity and Contrast
Sensitivity by Optomotor Reflex
in Rodents
Kaushikaram
Subramanian, PhD
Volker Enzmann, PhD
Research Director
Department of Ophthalmology
Inselspital,
University of Bern
Post Doctoral Researcher
Max Planck Institute of
Molecular Cell Biology & Genetics
Thomas Münch, PhD
Director of Research &
Development
Striatech
3. InsideScientific is an online
educational environment
designed for life science
researchers.
Our goal is to aid in the sharing
and distribution of scientific
information regarding
innovative technologies,
protocols, research tools and
laboratory services
4. To access webinar content,
Q&A reports,
FAQ documents,
and information on lab
workshops,
subscribe to our mail list
5. The Striatech Founders
Experts in applied ophthalmology & vision research
5
Dr. Thomas Münch |
Director for Research and Development
Neuroscientist
t.muench@stria.tech
Dr. Boris Benkner |
Managing Director
Neuroscientist
b.benkner@stria.tech
Marion Mutter | M. Sc., MBA
Chief Financial Officer
Neuroscientist
International Management
m.mutter@stria.tech
7. 7
• Reflex to stabilize the image of the
environment in the eye
• OMR initiates a head movement that
automatically follows an environmental
movement
The Optomotor Reflex
(OMR)
Only possible if the animal can (still) see!
8. 8
Measuring visual acuity and contrast sensitivity
based on OMR
✔
✔
✘
Visual acuityScientist Animal
Step-by-step procedure until
visual threshold is found
9. 9
Measuring visual acuity and contrast sensitivity
based on OMR
✔
✔
✘
Visual acuity Contrast sensitivityScientist Animal
Step-by-step procedure until
visual threshold is found
10. 10
ADVANTAGES
• No training required
• No fixation or surgery required
• Reflex exists directly after eye opening
• Longitudinal experiments possible
• Very robust
• For testing visual acuity and contrast sensitivity
OMR Pros & Cons
11. 11
ADVANTAGES
• No training required
• No fixation or surgery required
• Reflex exists directly after eye opening
• Longitudinal experiments possible
• Very robust
• For testing visual acuity and contrast sensitivity
CAUTION
• Reflex → No cortical vision is tested
• Depending on disease model, no effect on
optomotor reflex by moderate retinal damage
OMR Pros & Cons
12. DOWNSIDES OF MANUAL MEASUREMENTS
• Experimenter bias
• Non-consistent data
• Time consuming
12
Manual measurements vs.
automated analysis
Problems can be solved with a reliable
automated analysis.
14. How the OptoDrum works
14
1 Animal is placed in arena on elevated platform,
surrounded by computer monitors.
2 Stripe pattern slowly rotates around
animal, triggering optomotor reflex.
3 Camera observes animal behavior.
4 Behavior is automatically detected and
analyzed by OptoDrum software.
5 Stimulus pattern is continuously and automatically adjusted during experiment to
find animal‘s visual threshold (visual acuity or contrast sensitivity).
1
2
3
4
5
OptoDrum
15. What do the results look like?
Example: Retinal degeneration (rd10)
15
rd10 mice
Model for human Retinitis pigmentosa disease
Benkner et al. Behav Neurosci. (2013)
16. What do the results look like?
Example: Retinal degeneration (rd10)
16
Part I: Measuring contrast sensitivity
Contrast threshold (CTHR):
weakest contrast that still triggers the optomotor reflex
Contrast sensitivity: 1 / CTHR
Contrast sensitivity
✔
✔
✘
Benkner et al. Behav Neurosci. (2013)
17. What do the results look like?
Example: Retinal degeneration (rd10)
17
Part I: Measuring contrast sensitivity
0.05 cyc/°
Contrast sensitivity
✔
✔
✘
Benkner et al. Behav Neurosci. (2013)
18. What do the results look like?
Example: Retinal degeneration (rd10)
18
Part I: Measuring contrast sensitivity
0.05 cyc/° 0.15 cyc/° 0.3 cyc/°
Contrast sensitivity
✔
✔
✘
Benkner et al. Behav Neurosci. (2013)
19. What do the results look like?
Example: Retinal degeneration (rd10)
19
Part I: Measuring contrast sensitivity Contrast sensitivity
✔
✔
✘
Benkner et al. Behav Neurosci. (2013)
20. What do the results look like?
Example: Retinal degeneration (rd10)
20
Part II: Measuring visual acuity
Visual acuity threshold:
highest resolution (finest stripes) that still triggers the optomotor reflex
(usually measured at maximal contrast)
Contrast sensitivity
✔
✔
✘
Benkner et al. Behav Neurosci. (2013)
21. What do the results look like?
Example: Retinal degeneration (rd10)
21
Part II: Measuring visual acuity Visual acuity
✔
✔
✘
Benkner et al. Behav Neurosci. (2013)
22. What do the results look like?
Example: Retinal degeneration (rd10)
22
Part II: Measuring visual acuity Visual acuity
✔
✔
✘
Benkner et al. Behav Neurosci. (2013)
23. What do the results look like?
Example: Retinal degeneration (rd10)
23
Part II: Measuring visual acuity Visual acuity
✔
✔
✘
Benkner et al. Behav Neurosci. (2013)
24. What do the results look like?
Example: Retinal degeneration (rd10)
24
Contrast sensitivity function Visual acuity
✔
✔
✘
Benkner et al. Behav Neurosci. (2013)
25. Applications of optomotor reflex measurements
25
•Retinal degeneration
o rd10 animals
•Basic biological questions about vision
o Visual benefits of mouse rod nuclear architecture
•Pharmacological and toxicological studies
o Mimicking age-related macular degeneration with NaIO3
•Multiple Sclerosis
o Optic nerve damages
Dr. Thomas Münch
Prof. Dr. Volker Enzmann
Dr. Kaushikaram Subramanian
26. Relevance of the Rod Nuclear Architecture for
Animal’s Vision & Behavior
Copyright 2019 K. Subramanian and InsideScientific. All Rights Reserved.
Kaushikaram
Subramanian, PhD
Post Doctoral Researcher
Max Planck Institute of Molecular
Cell Biology & Genetics
27. 27
Relevance of the rod nuclear architecture for animal’s
vision & behavior
Consequences for vision
Tissue optical properties
Cellular architecture
30. Solovei et al. Cell (2009, 2013)
diurnal
pig, cow, macaque, human…
50 more species.
Conventional
architecture
pig
Rod cell
euchromatinheterochromatin
30
Nuclear Architecture
31. Solovei et al. Cell (2009, 2013)
diurnal
pig, cow, macaque, human…
50 more species.
Conventional
architecture
pig
nocturnal
Inverted
architecture
Mouse, rat, cat, rabbit, deer…
50 more species.
mice
Rod cell
euchromatinheterochromatin
31
Nuclear Architecture
32. Solovei et al. Cell (2009, 2013)
0 14 28 adult
Development (days after birth)
Lamin A/C & Lamin B receptor (LBR)
32
Cellular Architecture
33. Solovei et al. Cell (2009, 2013)
euchromatin heterochromatin
0 14 28 adult
Development (days after birth)
LBR over expression
Developmental arrest
chromocenters
Lamin A/C & Lamin B receptor (LBR)
33
Cellular Architecture
34. 34
Relevance of the rod nuclear architecture for animal’s
vision & behavior
Consequences for vision
Tissue optical properties
Cellular architecture
47. Quantification of Visual Acuity by OMR in the
Degenerated Mouse Retina – Pros and Cons
Copyright 2020 V. Enzmann and InsideScientific. All Rights Reserved.
Volker Enzmann, PhD
Research Director
Department of Ophthalmology
Inselspital,
University of Bern
48. Animal models of retinal degeneration
48
GENETIC MODELS
• rds mouse (peripherin mutation)
• rd mouse (phosphodiesterase 6B)
• RCS rat (Mertk mutation)
PHARMACOLOGICAL MODELS
• Methylnitrosourea (MNU) in different species
• Sodium iodate (NaIO3) in different species
• Induced Experimental autoimmune encephalomyelitis
(EAE)
KO MODELS
• RPE65-/- mouse
• Rho-/- mouse
LASER-INDUCED MODELS
• Argon laser-induced CNV in monkey
• Diode laser-induced damage in different species
Measurement of function is always important to validate the
animal model and quantify changes after treatment.
49. 49
Quantification of visual acuity by OMR in the
degenerated mouse retina
Induced Experimental autoimmune encephalomyelitis
Diode laser-induced damage
Sodium iodate (NaIO3)
50. 50
Quantification of visual acuity by OMR in the
degenerated mouse retina
Induced Experimental autoimmune encephalomyelitis
Diode laser-induced damage in different species
Sodium iodate (NaIO3)
51. 51
• Selective toxin for retinal pigment epithelium
(RPE, necrosis) followed by photoreceptor
death (apoptosis)
• No model for age-related macular degeneration
(AMD), but mimics symptoms of AMD
Sodium iodate (NaIO3) – Basics
• Concentration-dependent / Time-dependent
o Morphological changes: diminished RPE
autofluorescence, degenerated RPE layer, diminished
retina thickness (outer nuclear layer, ONL)
o Functional deficits: decrease in electroretinogram
(ERG), optomotor reflex
52. 52
Sodium iodate (NaIO3) – Function
Measurements
Optomotor Reflex Optical Coherence Tomography
camera
53. 53
Sodium iodate (NaIO3
) – Function
Correlation between morphological and functional changes
UninjuredD3D10
B
L
Untreated
D3
Untreated
D10
Untreated
BL
35m
g-Kg
N
aIO
3
D
3
35m
g-Kg
N
aIO
3
D10
35m
g-Kg
N
aIO
3
BL
50m
g-Kg
N
aIO
3
D3
50m
g-Kg
N
aIO
3
D10
50m
g-Kg
N
aIO
30.0
0.2
0.4
0.6
Time (days)
Visualacuity(C/°)
*
*p<0.05 and **p<0.01 vs the corresponding BL group
** **
Optomotor Reflex Optical Coherence Tomography
54. Sodium iodate (NaIO3)
54
Quantification of visual acuity by OMR in the
degenerated mouse retina
Induced Experimental autoimmune encephalomyelitis
Diode laser-induced damage
55. 55
Laser-induced Retinal Damage
GFAP/PCNA d3H&E d3
•Model of photoreceptor degeneration
•Focal damage in outer nuclear layer (ONL)
•Müller cell activation
•Scar formation
•No regeneration in the mouse
•Diode laser 532 nm
•Output power: 120 mW
•Aerial diameter: 100 µm
•Pulse duration: 60 ms
Mouse experimental set-up:
56. 56
Laser model & OMR
No correlation between morphological and functional changes
•532 nm diode laser, up to 30 spots (100 µm) around the optic nerve head
•Optomotor measurements at baseline & 7, 14, 21, and 28 days after laser damage
•No significant difference
n.s.
Optomotor Reflex Optical Coherence Tomography
57. 57
Conclusions
•Functional measurements depend on damage extent
•Detection of functional deficits in models w/ focal damage are difficult
•Methods needs to be evaluated
•Alternatives:
o Cued water maze
o Electroretinogram (ERG)
o Focal ERG
58. Diode laser-induced damage
Sodium iodate (NaIO3)
58
Quantification of visual acuity by OMR in the
degenerated mouse retina
Induced experimental autoimmune encephalomyelitis
59. Optic neuropathy – No animal model
Causes and Symptoms
•Optic neuropathy (also called optic neuritis) is inflammation of the optic nerve
•Temporary vision loss and pain are the two main symptoms
•Most people who suffer an episode of this condition fully recover their vision.
•Risk factors: adults aged 20-45 / women twice as likely as men
Visual field defects
Disc swelling
because of
inflammation
60. Is Experimental autoimmune encephalomyelitis
(EAE) a model for optic neuropathy?
Experimental autoimmune encephalomyelitis (EAE) model
•Most commonly used experimental model for multiple sclerosis (MS)
•Immunization w/ Myelin Oligodendrocyte Glycoprotein (MOG 35-55) emulsified in CFA
(Complete Freund’s Adjuvant)
•Augmented with 200 mg anti-MOG Ab (8-18C5)
61. Is Experimental autoimmune encephalomyelitis
(EAE) a model for optic neuropathy?
Induction of EAE
•Day 0
o i.p. injection of pertussis toxin (PTX)
o s.c. injection of MOG peptide
•Day 2
o i.p. injection of PTX
•Day 10
o i.v. injection of anti-MOG Ab
Disease Course
62. 62
Murine EAE disease course w/ and w/o monoclonal
MOG-IgG (8-18C5)
Visual acuity correlates with disease severity1
Functional measurement in EAE
Augmentation of EAE with the injection of monoclonal
MOG-IgG at day 10
1One measurement per animal was included in the analysis (last available measurement in controls, first measurement after onset of clinical signs in diseased
mice). | Spearman’s rho r=0.33, p=0.01
Control Non-augmented EAE Augmented EAE
63. 63
Therapeutic intervention ameliorates EAE score Visual function is preserved in treated mice1
Quantification of treatment effects
Treatment w/ neonatal Fc receptor (FcRn) as a
potential therapeutic option for optic neuropathy
1Significant decrease of visual acuity at follow-up in untreated animals vs. their baseline measurement (p=0.024, Wilcoxon’s signed rank test, line) and vs.
treated animals at follow-up (p=0.005, Mann-Whitney test, dashed line). ns= not significant.
64. 64
Conclusions
Pros
•Freely moving animals without anesthesia
•Fast and reliable measurement
•Automated detection
Cons
•High variability of the values
•Optomotor response vs. Optokinetic reflex
•No cell type-specific measurement
65. 65
Acknowledgements
Experimental Ophthalmology,
Dept. of Ophthalmology:
Ana Maria Quintela Pousa, PhD
Federica Maria Conedera, MSc
Stephanie Lötscher
Neuroimmunological Laboratory,
Dept. of Neurology
Anke Salmen, MD
Jana Remlinger, MSc
Adrian Madrasz
Funding partners:
Sutter-Stöttner-Stiftung
Thank you for the attention!
66. Kaushikaram
Subramanian, PhD
Volker Enzmann, PhD
Research Director
Department of Ophthalmology
Inselspital,
University of Bern
Post Doctoral Researcher
Max Planck Institute of
Molecular Cell Biology & Genetics
Thomas Münch, PhD
Director of Research &
Development
Striatech
For additional information on the products and applications presented
during this webinar, please contact the speakers below.
Thank you!